Cancer (journal): Difference between revisions
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Use dmy dates|date=October 2023}} | ||
{{Journal | |||
| title = Cancer | | title = Cancer | ||
| | | abbreviation = Cancer | ||
| discipline = [[Oncology]] | | discipline = [[Oncology]] | ||
| | | language = English | ||
| publisher = [[Wiley-Blackwell | | publisher = [[Wiley-Blackwell]] | ||
| country = United States | | country = United States | ||
| frequency = Biweekly | | frequency = Biweekly | ||
| history = 1948–present | | history = 1948–present | ||
| openaccess = | | openaccess = Hybrid | ||
| impact = 6.860 | |||
| impact = 6. | | impact-year = 2022 | ||
| impact-year = | | website = [https://acsjournals.onlinelibrary.wiley.com/journal/10970142 Official website] | ||
| website = | |||
| ISSN = 0008-543X | | ISSN = 0008-543X | ||
| eISSN = 1097-0142 | | eISSN = 1097-0142 | ||
}} | }} | ||
'''Cancer''' is a peer-reviewed [[scientific journal]] that focuses on the field of [[oncology]]. It is published by [[Wiley-Blackwell]] on behalf of the [[American Cancer Society]]. The journal was established in 1948 and has since become a leading source of information for researchers and clinicians in the field of cancer research and treatment. | |||
==Scope and Content== | |||
The journal covers a wide range of topics within oncology, including but not limited to: | |||
* [[Cancer biology]] | |||
* [[Cancer prevention]] | |||
* [[Cancer diagnosis]] | |||
* [[Cancer treatment]] | |||
* [[Cancer epidemiology]] | |||
*[[ | * [[Cancer genetics]] | ||
*[[ | * [[Cancer immunology]] | ||
* [[Cancer survivorship]] | |||
*[[ | |||
*[[ | The journal publishes original research articles, reviews, and editorials that contribute to the understanding and advancement of cancer research. It aims to provide comprehensive coverage of all aspects of cancer, from basic research to clinical applications. | ||
*[[ | |||
*[[ | ==Publication Frequency== | ||
*[[ | Cancer is published biweekly, providing timely updates and new findings in the field of oncology. This frequent publication schedule allows for the rapid dissemination of important research findings to the scientific community and healthcare professionals. | ||
*[[ | |||
==Editorial Process== | |||
The journal employs a rigorous peer-review process to ensure the quality and validity of the research it publishes. Manuscripts submitted to Cancer are evaluated by experts in the field, who assess the scientific merit, originality, and relevance of the work. The editorial board is composed of leading oncologists and researchers who guide the journal's content and direction. | |||
== | ==Impact and Influence== | ||
Cancer has a significant impact on the field of oncology, as evidenced by its impact factor of 6.860 as of 2022. The journal is widely read by oncologists, researchers, and healthcare professionals, and its articles are frequently cited in the scientific literature. Cancer is considered a valuable resource for those involved in cancer research and treatment. | |||
== | ==Open Access and Availability== | ||
Cancer offers a hybrid open access model, allowing authors to choose to make their articles freely available to the public. This model supports the dissemination of research findings to a broader audience, including patients, caregivers, and policymakers. | |||
==Related Pages== | |||
* [[Oncology]] | |||
* [[American Cancer Society]] | |||
* [[Wiley-Blackwell]] | |||
* [[Peer review]] | |||
* [[Impact factor]] | |||
[[Category:Oncology journals]] | [[Category:Oncology journals]] | ||
[[Category:Publications established in 1948]] | [[Category:Publications established in 1948]] | ||
[[Category: | [[Category:Biweekly journals]] | ||
[[Category:English-language journals]] | [[Category:English-language journals]] | ||
[[Category:Wiley-Blackwell academic journals]] | [[Category:Wiley-Blackwell academic journals]] | ||
Latest revision as of 19:21, 22 March 2025
Cancer is a peer-reviewed scientific journal that focuses on the field of oncology. It is published by Wiley-Blackwell on behalf of the American Cancer Society. The journal was established in 1948 and has since become a leading source of information for researchers and clinicians in the field of cancer research and treatment.
Scope and Content[edit]
The journal covers a wide range of topics within oncology, including but not limited to:
- Cancer biology
- Cancer prevention
- Cancer diagnosis
- Cancer treatment
- Cancer epidemiology
- Cancer genetics
- Cancer immunology
- Cancer survivorship
The journal publishes original research articles, reviews, and editorials that contribute to the understanding and advancement of cancer research. It aims to provide comprehensive coverage of all aspects of cancer, from basic research to clinical applications.
Publication Frequency[edit]
Cancer is published biweekly, providing timely updates and new findings in the field of oncology. This frequent publication schedule allows for the rapid dissemination of important research findings to the scientific community and healthcare professionals.
Editorial Process[edit]
The journal employs a rigorous peer-review process to ensure the quality and validity of the research it publishes. Manuscripts submitted to Cancer are evaluated by experts in the field, who assess the scientific merit, originality, and relevance of the work. The editorial board is composed of leading oncologists and researchers who guide the journal's content and direction.
Impact and Influence[edit]
Cancer has a significant impact on the field of oncology, as evidenced by its impact factor of 6.860 as of 2022. The journal is widely read by oncologists, researchers, and healthcare professionals, and its articles are frequently cited in the scientific literature. Cancer is considered a valuable resource for those involved in cancer research and treatment.
Open Access and Availability[edit]
Cancer offers a hybrid open access model, allowing authors to choose to make their articles freely available to the public. This model supports the dissemination of research findings to a broader audience, including patients, caregivers, and policymakers.